Starbucks Stages a Major Comeback. But Does That Mean You Should Buy It Now? Not So Fast.

Starbucks reported fiscal Q2 revenue up 9% year over year, comparable sales up 6.2%, and EPS up 32% to $0.45, driven mainly by stronger U.S. transactions. U.S. comps rose 7.1% with transactions up 4.4%, delivery increased 30% year to date, and cold foam sales grew 40%, while China posted a fourth straight transaction-led comps gain. Shares rose 7% after the report, though the stock still trades at 80x trailing earnings despite a 2.3% dividend yield.

Analysis

SBUX is transitioning from a multiple-driven relief rally to a fundamentals-driven rerating, but the market is now paying for a cleaner earnings inflection than the business has actually earned. The key second-order tell is transaction growth outpacing ticket growth: that usually marks a durable traffic reset rather than price-led comping, and it should help de-risk the latte tax narrative that has pressured premium coffee chains. If this holds for another 2-3 quarters, investors will start underwriting a higher steady-state comp base, which matters more than a one-quarter EPS beat.

The underappreciated beneficiary is the broader premium beverage and breakfast ecosystem: stronger cold beverage innovation and delivery penetration suggest Starbucks is reclaiming daypart relevance, which can pressure smaller regional coffee concepts and convenience-store chains reliant on coffee attach rates. The China monetization also removes a noisy balance-sheet and governance overhang, letting the market focus on operating leverage in the core brand rather than capital allocation drag. On the cost side, AI scheduling and store refreshes are likely to show up first as margin defense, not explosive margin expansion, so near-term upside is more about sales mix than cost savings.

The main risk is valuation compression if comps cool even modestly: at this multiple, any deceleration in traffic growth over the next 1-2 quarters could trigger a sharp derating because the stock is already discounting a multi-year turnaround. The bigger contrarian point is that the best case may already be visible in the numbers; if delivery and cold drink momentum normalize, the narrative shifts from turnaround to mature brand, which caps upside. For income buyers, the dividend is supportive, but for total-return investors the risk/reward looks more like a quality defensive name than a true post-crisis reacceleration play.

Key Decisions for Investors

• Do not chase SBUX after the print; wait for a 5-8% pullback or the next quarter to confirm that transaction growth remains positive before initiating a long.
• For existing longs, sell covered calls 1-2 months out against a portion of the position to monetize the premium multiple while preserving downside participation.
• Pair trade: long SBUX / short CMG or SBUX / short a basket of weaker premium-consumer names only if you want to express brand-strength dispersion; otherwise avoid relative-longing until valuation resets.
• If you want pure turnaround exposure, prefer a call spread instead of stock: buy 6-9 month SBUX $80/$95 call spreads to limit multiple-compression risk while keeping upside to continued traffic inflection.
• Watch the next two quarterly comp prints closely; if U.S. transaction growth slips below 2%, treat that as the signal to de-risk because the stock’s current multiple leaves little room for operational disappointment.